Clinical significance of anti-Ku autoantibodies - A serologic marker of overlap syndrome?

Internal Medicine

Volumn 41, Issue 12, 2002, Pages 1096-1098

  Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

DNA dependent protein kinase; Ku autoantigen; Overlap syndrome; Polymyositis; Scleroderma

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; COMPLEMENTARY DNA; DNA; DOUBLE STRANDED DNA; IMMUNOGLOBULIN CLASS; KU ANTIGEN; PROTEIN KINASE; PROTEIN P70; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; CAUCASIAN; CLINICAL FEATURE; CLINICAL PRACTICE; CONNECTIVE TISSUE DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; DISEASE MARKER; DNA RECOMBINATION; DNA REPAIR; DNA STRAND BREAKAGE; EDITORIAL; ETHNIC DIFFERENCE; GENE REARRANGEMENT; GENETIC VARIABILITY; GRAVES DISEASE; HUMAN; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOELECTROPHORESIS; JAPAN; NEGRO; NERVOUS SYSTEM DEVELOPMENT; POLYMYOSITIS; PROTEIN FUNCTION; PROTEIN TARGETING; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; TELOMERE;

EID: 0036970827     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.1096     Document Type: Editorial

References (32)

1. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 68: 611-620, 1981.
2. Reeves WH. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med 161: 18-39, 1985.
3. Francoeur AM, Peebles CL, Gompper PT, Tan EM. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol 136: 1648-1653, 1986.
4. Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 261: 2274-2278, 1986.
5. Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem 261: 10375-10379, 1986.
6. Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72: 131-142, 1993.
7. Suwa A, Hirakata M, Takeda Y, Jesch SA, Mimori T, Hardin JA. DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci USA 91: 6904-6908, 1994.
8. Rathmell WK, Chu G. Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc Natl Acad Sci USA 91: 7623-7627, 1994.
9. Taccioli GE, Gottlieb TM, Blunt T, et al. Ku 80: Product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265: 1442-1445, 1994.
10. Smider V, Rathmell WK, Lieber MR, Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266: 288-291, 1994.
11. Boubnov NV, Hall KT, Wills Z, et al. Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86 Ku autoantigen. Proc Natl Acad Sci USA 92: 890-894, 1995.
12. Boulton SJ, Jackson SP. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J 17: 1819-1828, 1998.
13. Casellas R, Nussenzweig A, Wuerffel R, et al. Ku80 is required for immunoglobulin isotype switching. EMBO 117: 2404-2411, 1998.
14. Bakalkin G, Yakovleva T, Hurd YL, Nussenzweig A, Li GC, Terenius L. Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization. Neuroreport 9: 2147-2151, 1998.
15. Mimori T, Hama N, Suwa A, et al. Genomic structure and gene family of the human autoantigen Ku (p70/p80). Arthritis Rheum 36: S106, 1993 (Abstract).
16. Myung K, He DM, Lee SE, Hendrickson EA. KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity. EMBO J 16: 3172-3184, 1997.
17. Muller C, Dusseau C, Calsou P, Salles B. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein. Oncogene 16: 1553-1560, 1998.
18. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 76: 366-312, 1989.
19. Yamamoto AM, Amoura Z, Johannet C, et al. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum 43: 689-698, 2000.
20. Wang J, Satoh M, Kabir F, et al. Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 44: 2367-2370, 2001.
21. Isern RA, Yaneva M, Weiner E, et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 93: 307-312, 1992.
22. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al: Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40: 1257-1266, 1997.
23. Cooley HM, Melny BJ, Gleeson R, Greco T, Kay TW. Clinical and serological associations of anti-Ku antibody. J Rheumatol 26: 563-567, 1999.
24. Franceschini F, Cavazzana I, Generali D, et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 29: 1393-1397, 2002.
25. Yamanishi Y, Maeda H, Katayama S, Ishioka S, Yamakido M. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation. J Rheumatol 23: 1991-1994, 1996.
26. Nitta Y, Muramatsu M. A juvenile case of overlap syndrome of systemic lupus erythematosus and polymyositis, later accompanied by systemic sclerosis with the development of anti-Scl 70 and anti-Ku antibodies. Pediatr Dermatol 17: 381-383, 2000.
27. Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman ED. Localized scleroderma progressing to systemic disease. Case report and review of the literature [published erratum appears in Arthritis Rheum 36: 1182, 1993]. Arthritis Rheum 36: 410-415, 1993.
28. Kamei N, Yamane K, Yamashita Y, et al. Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura. Intern Med 41: 1199-1203, 2002.
29. Reeves WH, Sthoeger ZM. Molecular cloning of cDNA encoding the p70 (Ku) lupus autoantigen. J Biol Chem 264: 5047-5052, 1989.
30. Yaneva M, Wen J, Ayala A, Cook R. cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J Biol Chem 264: 13407-13411, 1989.
31. Mimori T, Ohosone Y, Hama N, et al. Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc Natl Acad Sci USA 87: 1777-1781, 1990.
32. Chan JY, Lerman MI, Prabhakar BS, et al. Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. J Biol Chem 264: 3651-3654, 1989.